HST Global, Inc. Share Price

Equities

HSTC

US40432E2028

Biotechnology & Medical Research

Market Closed - OTC Markets 20:10:38 26/04/2024 BST 5-day change 1st Jan Change
1.11 USD +18.09% Intraday chart for HST Global, Inc. -0.89% +82.72%
Sales 2022 - Sales 2023 - Capitalization 3.19M 255M
Net income 2022 - 0 Net income 2023 - 0 EV / Sales 2022 -
Net Debt 2022 75.89K 6.08M Net Debt 2023 96.79K 7.75M EV / Sales 2023 -
P/E ratio 2022
-4.34 x
P/E ratio 2023
-21.8 x
Employees 2
Yield 2022 *
-
Yield 2023
-
Free-Float 37.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day+18.09%
1 week-0.89%
Current month+30.59%
1 month+30.59%
3 months+109.39%
6 months+117.69%
Current year+82.72%
More quotes
1 week
0.65
Extreme 0.65
1.11
1 month
0.65
Extreme 0.65
1.15
Current year
0.36
Extreme 0.3557
1.15
1 year
0.10
Extreme 0.1011
1.15
3 years
0.07
Extreme 0.071
1.15
5 years
0.00
Extreme 0
1.15
10 years
0.00
Extreme 0
1.15
More quotes
Managers TitleAgeSince
Chief Executive Officer 75 07/05/08
Members of the board TitleAgeSince
Chief Executive Officer 75 07/05/08
More insiders
Date Price Change Volume
26/04/24 1.11 +18.09% 2,600
25/04/24 0.94 +44.62% 1,000

Delayed Quote OTC Markets, April 26, 2024 at 08:10 pm

More quotes
HST Global, Inc. is an integrated health and wellness biotechnology company. The Company is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The Company intends to acquire innovative products for the treatment of life-threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The Company has not generated any revenue.
More about the company